Emily Capodilupo, WHOOP VP of Data Science and Research, returns to the WHOOP Podcast to detail our latest COVID-19 vaccine research. We've found that younger people are more likely to be affected by the vaccine than older people. Additionally, you should expect to feel more rundown by the second dose than the first, but any vaccine aftereffects are short l ... Show More
Today
How To Build Endurance with 8-Time Cyclocross World Champion, Mathieu van der Poel
In this month’s edition of the How To Series, WHOOP Founder & CEO Will Ahmed sits down with one of the world’s most dominant cyclists, Mathieu van der Poel. Will and van der Poel sit down to unpack hope to perform across disciplines, sustain longevity in elite-level sport, and em ... Show More
34m 59s
Feb 4
How 23-Time Gold Medalist, Michael Phelps, Manages Stress & Mental Health
This week, on the WHOOP Podcast, WHOOP Founder & CEO Will Ahmed sits down with 23-time gold medalist, Michael Phelps. Michael opens up about his experience coming up as a swimmer, reflecting on impactful changes that could benefit the sports future successes. Michael shares perso ... Show More
45m 57s
Jan 28
How AI & Wearables Are Shaping The Future of Healthcare with Dr. Ami Bhatt
The WHOOP Podcast Longevity Series is back! This week, WHOOP SVP of Research, Algorithms, and Data, Emily Capodilupo sits down with Dr. Ami Bhatt, renowned cardiologist, Chief Innovation Officer at the American College of Cardiology, and Chair of the Digital Health Advisory Commi ... Show More
34m 50s
Dec 2020
COVID-19 Chapter 13: Vaccines, Take 2
<p>We’re back with another episode in our Anatomy of a Pandemic series on COVID-19. This time, our subject matter is the one everyone has been waiting for: vaccines. In this episode, with the help of two amazing guests, we attempt to answer all of your burning questions about the ... Show More
1h 19m
Sep 2020
What We Can't Know About a Vaccine
The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ... Show More
13m 57s
Jan 2021
The Real Story About COVID Vaccines: What We Know, What We Don’t with Dale Harrison
The Real Story About COVID Vaccines: What We Know, What We Don’t | This episode is brought to you by Bioptimizers, Thrive Market, and Athletic Greens. There’s no way around it, we’re being bombarded by an insane amount of information when it comes to COVID-19, and not all of it m ... Show More
1h 55m
Jun 2021
Covipod #9 : Le vaccin, moins efficace chez certaines personnes
<p>Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ... Show More
5m 43s
Oct 2020
Will People Accept a COVID-19 Vaccine? With Gretchen Chapman, PhD
Scientists are racing to develop a safe, effective, vaccine for COVID-19 – but will people be willing to take it when it's available? We already have a flu vaccine, but less than half of Americans get it each year. Gretchen Chapman, PhD, a cognitive psychologist who studies healt ... Show More
26m 43s
Nov 2021
Kids’ Vaccines Tackle COVID-19
What do you need to know about the new COVID-19 vaccines for ages 5 - 11? Sam, age 8, and Natalie, age 10, are here to help! They participated in a COVID vaccine trial, which is an important part of the science that will help end the threat of coronavirus. Along with Dr. Kawsar T ... Show More
18m 26s